Cardiac risk factors and participation guidelines for youth sports

Pediatric Clinics of North America

Volumn 49, Issue 4, 2002, Pages 681-707

  Luckstead Sr , Eugene F ^a  

^a Texas Tech School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ACCURACY; ADOLESCENCE; ATHLETE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; DIAGNOSTIC PROCEDURE; ENDOCARDITIS; EXERCISE; HEART ARRHYTHMIA; HEART DEATH; HEART MURMUR; HUMAN; HYPERTENSION; LONG QT SYNDROME; MEDICAL ASSESSMENT; MEDICOLEGAL ASPECT; MYOCARDITIS; PALLIATIVE THERAPY; PERICARDITIS; PRACTICE GUIDELINE; REVIEW; SPORT INJURY; SUDDEN DEATH; SYNCOPE; THORAX PAIN; TRAINING;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; GUIDELINES; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; RISK ASSESSMENT; RISK FACTORS; SPORTS; SPORTS MEDICINE;

EID: 0036695069     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(02)00015-9     Document Type: Review

References (176)

1. Effective use of the consultant, laboratory testing and echocardiography for the pediatric patient with heart murmur
2. Risk profiles and cardiovascular preparticipation screening of competitive athletes
3. Echocardiographic findings in children participating in swimming training
4. The athlete's heart: A meta-analysis of cardiac structure and function
5. Preparticipation examination of the adolescent athlete (part 2)
6. Does preseason screening for cardiac disease really work?. The British perspective
7. Current use of adequate preparticipation history forms for heart disease screening of high school athletes
8. New perspectives in childhood blood pressure
9. Cardiovascular disease in athletes
10. Sudden death from cardiac causes in children and young adults
11. Sudden death in athletes
12. Sudden death in young athletes: Lessons from the Hank Gaithers affair
13. Cardiac disease in young trained athletes: Insights into distinguishing athletes' heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy
14. Report of the Second Task Force on Blood Pressure Control in Children
15. The long QT syndrome
16. Sudden cardiac death in infants, children and adolescents
17. Profile of preparticipation cardiovascular screening for high school athletes
18. Cardiovascular screening of student athletes
19. Sudden death in young athletes
20. Structural features of the athlete's heart: As defined by echocardiography
21. Cardiovascular risks to young persons on the athletic field
22. Tall stature
23. Cardiovascular evaluation of the young athlete
24. Task force on sudden cardiac death of the European society of cardiology
25. Exercise and the Marfan syndrome
26. The long QT syndrome. A review of recent molecular genetic and physiologic discoveries
27. Comparison of auscultatory and oscillometric blood pressures
28. Syncope associated with exercise, a manifestation of neurally-mediated syncope
29. The management of hypertrophic cardiomyopathy
30. The preparticipation physical examination history: Who has the correct answers?
31. Preparticipation evaluation for athletes
32. The adolescent athlete: Assessment for sports participation
33. Athlete's heart
34. Childhood hypertension: An update on etiology, diagnosis and treatment
35. Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986-1996
36. Nontraumatic sports death in high school and college athletes
37. The electrocardiogram in the highly trained athlete
38. Accuracy of blood pressure measurement by Dinamap monitor in infants and children
39. Hypertension in children and adolescents
40. Hypertension in children and adolescence
41. Preparticipation examination of the adolescent athlete (part 1)
42. Innocent murmurs and heart sounds
43. The physiological load imposed on basketball players during competition
44. 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities (Task Force 2: Acquired valvular heart disease)
45. 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities (Task Force 1: Congenital heart disease)
46. Evaluation of heart murmurs
47. Hypertension in children and adolescents: Definition, pathophysiology. Risk factors and long-term sequelae
48. Recreational and sports recommendations for the child with heart disease
49. Development, implementation and validation of the Canadian intercollegiate sports injury registry
50. Exercise for children
51. Athlete's heart in prepubertal children
52. Syncope in the ahlete
53. Health-related fitness as preventive medicine
54. Normal blood pressures and the evaluation of sustained blood pressure elevation in childhood: The Muscatine study
55. Scientific, medical and practical aspects of stretching
56. Does endurance training benefit the cardiovascular system?
57. Clinical auscultation skills in pediatric residents
58. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program
59. Blood pressure in obese adolescents: Effect of weight loss
60. Molecular basis of the long QT syndrome associated with deafness
61. Ambulatory blood pressure monitoring in the evaluation of pediatric disorders
62. Childhood risk factors for high adult blood pressure: The Muscatine study
63. Level, trend and variability of blood pressure during childhood: The Muscatine study
64. Left ventricular contractility and function in Kawasaki syndrome: Effect of intravenous gamma-globulin
65. Guidelines for exercise testing in the pediatric age group
66. Sudden cardiac death in air force recruits: A 20 year review
67. Twenty-four hour ambulatory blood pressure monitoring. Now that technology has come of age - We need to catch up
68. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity: A report of 80 cases
69. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome
70. Chest pain in otherwise healthy children and adults is frequently caused by exercise-induced asthma
71. Antihypertensive agents: Mechanisms of action, safety profiles and current uses in children
72. Labeling antihypertensive agents for children
73. The testing of antihypertensive medications in children: Report of the Antihypertensive Agent Guidelines Subcommittee of the Pediatric Pharmacology Research Units
74. Treatment of hypertension
75. Chest pain in children
76. Prevalence of "significant" hypertension in junior high school-aged children: the children and adolescent blood pressure program
77. Myocardititis
78. Clinicopathologic description of myocardititis
79. How common is white coat hypertension?
80. Evaluation of hypercholesterolemia in childhood
81. Pericarditis
82. Cocaine and chest pain: Clinical features and outcome of patients hospitalized to rule out myocardial infarction
83. High school association declines national PPE
84. Chest roentgenograms in the evaluation of heart defects in asymptomatic infants and children with a cardiac murmur: Reproducibility and accuracy
85. Sudden death in children and young adults
86. Preparticpation screening of US collegiate student-athletes
87. Immunosuppressive therapy in the management of acute myocarditis in children
88. Noninvasive tests in the initial evaluation of heart murmurs in children
89. Collapse of the right ventricle with cardiac tamponade: An echocardiographic study
90. Arrhythmias and sudden cardiac death in elite athletes [American College of Cardiology: 16th Bethesda Conference]
91. Sudden unexpected death in children and adolescents
92. Echocardiographic documented mitral valve prolapse: Long-term follow-up of 237 patients
93. Outer limits of physiologic hypertrophy and relevance to the diagnosis of primary cardiac disease
94. Athlete's heart electrocardiogram mimicking hypertrophic cardiomyopathy
95. Athlete's heart in women: Echocardiographic characterization of highly trained elite female athletes
96. Clinical significance of abnormal electrocardiograhic patterns in trained athletes
97. How to distinguish between innocent and pathologic murmurs in childhood
98. The long QT syndrome: Prospective longitudinal study of 328 families
99. The upper limit of physiologic cardiac hypertrophy in highly trained athletes
100. Cardiac causes of syncope in the adolescent
101. Syncope in the pediatric patient: Diagnosis, pathophysiology and treatment
102. Sudden cardiac death
103. The prolonged QT syndrome
104. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block and neurocardiogenic syncope
105. Cardiac responses to progressive exercise in normal children: A synthesis
106. Hypertension in children
107. Role of exercise in the management of cardiovascular disease in children and youth
108. Causes of sudden death in athletes
109. Aortic root dilatation among young competitive athletes: Echocardiographic screening of 1929 athletes between 15 and 34 years of age
110. Congenital cardiovascular disease: The major cause of athletic death in high school and college
111. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes
112. Prospective echocardiographic screening for coronary artery anomalies in 1360 elite competitive athletes
113. Exercise capacity in children with hypertrophic cardiomyopathy and its relation to diastolic left ventricular function
114. Sudden death in young people with apparently isolated mitral valve prolapse
115. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: The Bogalusa heart study
116. Recent advances in the treatment of primary pulmonary artery hypertension
117. Cisapride-induced long QT interval
118. The long QT syndrome in children. An international study of 287 patients
119. The new world of pediatric cardiology: Issues and answers
120. Syncope in the child and adolescent
121. Prospective screening of 56,115 high school athletes for risk of sudden cardiac death
122. The clinical spectrum of commotio cordis: The first 100 cases from the US registry
123. The cardiac murmur: When to refer?
124. Pericarditis
125. Exercise-induced vasodepressor syncope
126. Spectrum of clinico-pathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study
127. Athletic participation by children and adolescents who have systemic hypertension
128. What's new in cardiology: An update of current clinical practices
129. Clinical preservation and long-term follow-up of athletes with exercise-induced vasodepressor syncope
130. A practical approach to the evaluation of antihypertensive agents in infants and children: Study design and outcome measures
131. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study
132. Exercise ECG: Prognostic implications of exercise-induced arrhythmias pacing
133. Infective endocarditis
134. Pediatric sudden cardiac death: What the pediatrician needs to know
135. ECG findings in active patients: Differentiating the benign from the serious
136. Validity of mass blood pressure screening in children
137. Pediatric use of antihypertensive medications: Much more to learn
138. Cardiac issues in the pediatric emergency room
139. Prevalence and clinical outcome of mitral valve prolapse
140. Cardiac rehabilitation in congenital heart disease
141. Preparticipation sports assessment: An objective evaluation
142. Management of infants, children and adolescents with paroxysmal supraventricular tachycardia
143. EKG screening program for school athletes
144. Screening for hypertrophic cardiomyopathy in the preparticipation athletic exam: Feasibility and cost using a hand-held ultrasound device
145. What is commotio cordis?
146. Syncope in the pediatric patient: The cardiologist's perspective
147. Eligibility recommendations for competitive athletes with cardiovascular abnormalities
148. Sudden death in young athletes
149. Value and limitations of auscultation in the management of congenital heart disease
150. Classification of sports
151. Effects of long-term endurance training on left ventricular dimensions and function in female distance runners
152. The child who passes out
153. The Marfan syndrome
154. Sports and Marfan syndrome: Awareness and early diagnosis can prevent sudden death
155. Myocarditis
156. Integrated cardiovascular health promotion in childhood
157. Automated cardiac auscultation for detection of pathologic heart murmurs
158. Cardiac dysrhythmias
159. Exercise-associated cardiac asystole in persons without organic heart disease
160. Transitions of cardiovascular risk from adolescence to young adulthood-the Bogalusa heart study. II. Alterations in anthropometric blood pressure and serum lipoprotein variables
161. Approach to the use of antihypertensive drugs in children and adolescents
162. Syncope
163. Chest pain secondary to cocaine use
164. Natural history of mitral valve prolapse